ZEPP vs FITB

For growth investors, Fifth Third Bancorp (FITB) is the stronger pick with 5.

6% revenue growth year-over-year, versus -46. 6% for Zepp Health Corporation (ZEPP). Fifth Third Bancorp (FITB) offers the better valuation at 15. 7x trailing P/E (16. 0x forward), making it the more compelling value choice. Analysts rate Fifth Third Bancorp (FITB) a "Buy" — based on 51 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Fifth Third Bancorp is actually cheaper at 16.

0x.

Over the past 5 years, Fifth Third Bancorp (FITB) delivered a total return of +33.

0%, compared to -66. 4% for Zepp Health Corporation (ZEPP). Over 10 years, the gap is even starker: FITB returned +247. 5% versus ZEPP's -72. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Fifth Third Bancorp (FITB) is the lower-risk stock at 1.

08β versus Zepp Health Corporation's 1. 66β — meaning ZEPP is approximately 54% more volatile than FITB relative to the S&P 500. On balance sheet safety, Zepp Health Corporation (ZEPP) carries a lower debt/equity ratio of 72% versus 97% for Fifth Third Bancorp — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Fifth Third Bancorp (FITB) is pulling ahead at 5.

6% versus -46. 6% for Zepp Health Corporation (ZEPP). On earnings-per-share growth, the picture is similar: Fifth Third Bancorp grew EPS -2. 5% year-over-year, compared to -1642. 9% for Zepp Health Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Fifth Third Bancorp (FITB) is the more profitable company, earning 17.

7% net margin versus -41. 6% for Zepp Health Corporation — meaning it keeps 17. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FITB leads at 22. 3% versus -25. 9% for ZEPP. At the gross margin level — before operating expenses — FITB leads at 59. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Fifth Third Bancorp (FITB) trades at 16.

0x forward P/E versus 177. 0x for Zepp Health Corporation — 161. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FITB: 14. 5% to $56. 50.

In this comparison, FITB (3.

5% yield) pays a dividend. ZEPP does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Fifth Third Bancorp (FITB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

08), 3. 5% yield, +247. 5% 10Y return). Zepp Health Corporation (ZEPP) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FITB: +247. 5%, ZEPP: -72. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ZEPP (Technology) and FITB (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ZEPP is a small-cap quality compounder stock; FITB is a mid-cap deep-value stock. FITB pays a dividend while ZEPP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.